BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15148528)

  • 1. The promise of thalidomide: evolving indications.
    Joglekar S; Levin M
    Drugs Today (Barc); 2004 Mar; 40(3):197-204. PubMed ID: 15148528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalidomide for erythema nodosum leprosum and other applications.
    Okafor MC
    Pharmacotherapy; 2003 Apr; 23(4):481-93. PubMed ID: 12680478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential novel uses of thalidomide: focus on palliative care.
    Peuckmann V; Fisch M; Bruera E
    Drugs; 2000 Aug; 60(2):273-92. PubMed ID: 10983733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thalidomide: new uses for an old drug].
    Wu KL; Sonneveld P
    Ned Tijdschr Geneeskd; 2002 Aug; 146(31):1438-41. PubMed ID: 12190008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalidomide: current and potential clinical applications.
    Calabrese L; Fleischer AB
    Am J Med; 2000 Apr; 108(6):487-95. PubMed ID: 10781782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of thalidomide's history and current dermatological applications.
    Perri AJ; Hsu S
    Dermatol Online J; 2003 Aug; 9(3):5. PubMed ID: 12952752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thalidomide: new perspectives for its use as antiinflammatory, immunossupressive and antiangiogenic drug].
    Borges Lde G; Frõehlich PE
    Rev Assoc Med Bras (1992); 2003; 49(1):96-102. PubMed ID: 12724820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalidomide's effectiveness in erythema nodosum leprosum is associated with a decrease in CD4+ cells in the peripheral blood.
    Shannon EJ; Ejigu M; Haile-Mariam HS; Berhan TY; Tasesse G
    Lepr Rev; 1992 Mar; 63(1):5-11. PubMed ID: 1569817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of erythema nodosum leprosum using thalidomide].
    Sheskin J
    Acta Leprol; 1983; 1(1):41-50. PubMed ID: 6401140
    [No Abstract]   [Full Text] [Related]  

  • 10. Potential of thalidomide and thalidomide analogues as immunomodulatory drugs in leprosy and leprosy reactions.
    Kaplan G
    Lepr Rev; 2000 Dec; 71 Suppl():S117-20. PubMed ID: 11201867
    [No Abstract]   [Full Text] [Related]  

  • 11. Thalidomide in multiple myeloma--clinical trials and aspects of drug metabolism and toxicity.
    Breitkreutz I; Anderson KC
    Expert Opin Drug Metab Toxicol; 2008 Jul; 4(7):973-85. PubMed ID: 18624684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etanercept in erythema nodosum leprosum.
    Santos JRS; Vendramini DL; Nery JADC; Avelleira JCR
    An Bras Dermatol; 2017; 92(4):575-577. PubMed ID: 28954119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thalidomide. A new beginning.
    Valorie AM
    Cancer Pract; 2000; 8(2):101-3. PubMed ID: 11898173
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chemotherapy-induced erythema nodosum leprosum: successful treatment with thalidomide].
    Petering H; Kiehl P; Vogelbruch M; Sticht-Groh V; Kapp A; Werfel T
    Hautarzt; 2001 Oct; 52(10 Pt 2):966-9. PubMed ID: 11715395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of erythema nodosum leprosum by thalidomide: thalidomide analogues inhibit M. leprae-induced TNFalpha production in vitro.
    Sampaio EP; Hernandez MO; Carvalho DS; Sarno EN
    Biomed Pharmacother; 2002 Feb; 56(1):13-9. PubMed ID: 11905505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalidomide in the treatment of leprosy.
    Teo S; Resztak KE; Scheffler MA; Kook KA; Zeldis JB; Stirling DI; Thomas SD
    Microbes Infect; 2002 Sep; 4(11):1193-202. PubMed ID: 12361920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalidomide: a review of approved and investigational uses.
    Matthews SJ; McCoy C
    Clin Ther; 2003 Feb; 25(2):342-95. PubMed ID: 12749503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theoretical basis for the activity of thalidomide.
    Meierhofer C; Dunzendorfer S; Wiedermann CJ
    BioDrugs; 2001; 15(10):681-703. PubMed ID: 11604049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide in cancer medicine.
    Eleutherakis-Papaiakovou V; Bamias A; Dimopoulos MA
    Ann Oncol; 2004 Aug; 15(8):1151-60. PubMed ID: 15277253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thalidomide: emerging role in cancer medicine.
    Richardson P; Hideshima T; Anderson K
    Annu Rev Med; 2002; 53():629-57. PubMed ID: 11818493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.